(Q61864860)
Statements
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab (FCFD4514S) in Patients With Geographic Atrophy Who Have Completed Genentech-Sponsored Lampalizumab Studies (English)
0 references
29 May 2012
0 references
8 November 2017
0 references
159
0 references
60 year
0 references
89 year
0 references